Medical Care

Global Lipid-Based Nanodelivery System Market Research Report 2025

The global market for Lipid-Based Nanodelivery System was valued at US$ 924 million in the year 2024 and is projected to reach a revised size of US$ 2164 million by 2031, growing at a CAGR of 12.3% during the forecast period.
A lipid-based nanodelivery system is a nanoscale carrier composed primarily of lipid materials such as phospholipids, solid lipids, or oils, designed to efficiently and safely deliver drugs or bioactive molecules to target sites in the body. These systems can encapsulate both hydrophilic and hydrophobic compounds, enhancing solubility, stability, and bioavailability, while enabling controlled release, targeted delivery, and reduced side effects. Common types include liposomes, solid lipid nanoparticles (SLNs), and nanostructured lipid carriers (NLCs), with wide applications in anticancer drugs, vaccines, nucleic acid therapeutics, and other bioactive agents.
North American market for Lipid-Based Nanodelivery System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lipid-Based Nanodelivery System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Lipid-Based Nanodelivery System in Gene Therapy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Lipid-Based Nanodelivery System include Cytiva, Croda International, Evonik, Merck KGaA, Genevant Sciences, Nippon Fine Chemical, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lipid-Based Nanodelivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid-Based Nanodelivery System.
The Lipid-Based Nanodelivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lipid-Based Nanodelivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lipid-Based Nanodelivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cytiva
Croda International
Evonik
Merck KGaA
Genevant Sciences
Nippon Fine Chemical
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
Creative Biolabs
GenScript
WuXi STA
MicroNano Biologics
Precigenome
Catalent
Wacker
Segment by Type
mRNA-lipid Nanoparticle
siRNA-lipid Nanoparticle
Liposomes
Other
Segment by Application
Gene Therapy
Vaccine
Cancer Treatment
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lipid-Based Nanodelivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lipid-Based Nanodelivery System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 mRNA-lipid Nanoparticle
1.2.3 siRNA-lipid Nanoparticle
1.2.4 Liposomes
1.2.5 Other
1.3 Market by Application
1.3.1 Global Lipid-Based Nanodelivery System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Vaccine
1.3.4 Cancer Treatment
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lipid-Based Nanodelivery System Market Perspective (2020-2031)
2.2 Global Lipid-Based Nanodelivery System Growth Trends by Region
2.2.1 Global Lipid-Based Nanodelivery System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lipid-Based Nanodelivery System Historic Market Size by Region (2020-2025)
2.2.3 Lipid-Based Nanodelivery System Forecasted Market Size by Region (2026-2031)
2.3 Lipid-Based Nanodelivery System Market Dynamics
2.3.1 Lipid-Based Nanodelivery System Industry Trends
2.3.2 Lipid-Based Nanodelivery System Market Drivers
2.3.3 Lipid-Based Nanodelivery System Market Challenges
2.3.4 Lipid-Based Nanodelivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lipid-Based Nanodelivery System Players by Revenue
3.1.1 Global Top Lipid-Based Nanodelivery System Players by Revenue (2020-2025)
3.1.2 Global Lipid-Based Nanodelivery System Revenue Market Share by Players (2020-2025)
3.2 Global Top Lipid-Based Nanodelivery System Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lipid-Based Nanodelivery System Revenue
3.4 Global Lipid-Based Nanodelivery System Market Concentration Ratio
3.4.1 Global Lipid-Based Nanodelivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lipid-Based Nanodelivery System Revenue in 2024
3.5 Global Key Players of Lipid-Based Nanodelivery System Head office and Area Served
3.6 Global Key Players of Lipid-Based Nanodelivery System, Product and Application
3.7 Global Key Players of Lipid-Based Nanodelivery System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lipid-Based Nanodelivery System Breakdown Data by Type
4.1 Global Lipid-Based Nanodelivery System Historic Market Size by Type (2020-2025)
4.2 Global Lipid-Based Nanodelivery System Forecasted Market Size by Type (2026-2031)
5 Lipid-Based Nanodelivery System Breakdown Data by Application
5.1 Global Lipid-Based Nanodelivery System Historic Market Size by Application (2020-2025)
5.2 Global Lipid-Based Nanodelivery System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lipid-Based Nanodelivery System Market Size (2020-2031)
6.2 North America Lipid-Based Nanodelivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lipid-Based Nanodelivery System Market Size by Country (2020-2025)
6.4 North America Lipid-Based Nanodelivery System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lipid-Based Nanodelivery System Market Size (2020-2031)
7.2 Europe Lipid-Based Nanodelivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lipid-Based Nanodelivery System Market Size by Country (2020-2025)
7.4 Europe Lipid-Based Nanodelivery System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Lipid-Based Nanodelivery System Market Size (2020-2031)
8.2 Asia-Pacific Lipid-Based Nanodelivery System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lipid-Based Nanodelivery System Market Size by Region (2020-2025)
8.4 Asia-Pacific Lipid-Based Nanodelivery System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Lipid-Based Nanodelivery System Market Size (2020-2031)
9.2 Latin America Lipid-Based Nanodelivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lipid-Based Nanodelivery System Market Size by Country (2020-2025)
9.4 Latin America Lipid-Based Nanodelivery System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lipid-Based Nanodelivery System Market Size (2020-2031)
10.2 Middle East & Africa Lipid-Based Nanodelivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lipid-Based Nanodelivery System Market Size by Country (2020-2025)
10.4 Middle East & Africa Lipid-Based Nanodelivery System Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cytiva
11.1.1 Cytiva Company Details
11.1.2 Cytiva Business Overview
11.1.3 Cytiva Lipid-Based Nanodelivery System Introduction
11.1.4 Cytiva Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.1.5 Cytiva Recent Development
11.2 Croda International
11.2.1 Croda International Company Details
11.2.2 Croda International Business Overview
11.2.3 Croda International Lipid-Based Nanodelivery System Introduction
11.2.4 Croda International Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.2.5 Croda International Recent Development
11.3 Evonik
11.3.1 Evonik Company Details
11.3.2 Evonik Business Overview
11.3.3 Evonik Lipid-Based Nanodelivery System Introduction
11.3.4 Evonik Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.3.5 Evonik Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Lipid-Based Nanodelivery System Introduction
11.4.4 Merck KGaA Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.4.5 Merck KGaA Recent Development
11.5 Genevant Sciences
11.5.1 Genevant Sciences Company Details
11.5.2 Genevant Sciences Business Overview
11.5.3 Genevant Sciences Lipid-Based Nanodelivery System Introduction
11.5.4 Genevant Sciences Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.5.5 Genevant Sciences Recent Development
11.6 Nippon Fine Chemical
11.6.1 Nippon Fine Chemical Company Details
11.6.2 Nippon Fine Chemical Business Overview
11.6.3 Nippon Fine Chemical Lipid-Based Nanodelivery System Introduction
11.6.4 Nippon Fine Chemical Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.6.5 Nippon Fine Chemical Recent Development
11.7 Polymun Scientific
11.7.1 Polymun Scientific Company Details
11.7.2 Polymun Scientific Business Overview
11.7.3 Polymun Scientific Lipid-Based Nanodelivery System Introduction
11.7.4 Polymun Scientific Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.7.5 Polymun Scientific Recent Development
11.8 Corden Pharma
11.8.1 Corden Pharma Company Details
11.8.2 Corden Pharma Business Overview
11.8.3 Corden Pharma Lipid-Based Nanodelivery System Introduction
11.8.4 Corden Pharma Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.8.5 Corden Pharma Recent Development
11.9 Acuitas Therapeutics
11.9.1 Acuitas Therapeutics Company Details
11.9.2 Acuitas Therapeutics Business Overview
11.9.3 Acuitas Therapeutics Lipid-Based Nanodelivery System Introduction
11.9.4 Acuitas Therapeutics Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.9.5 Acuitas Therapeutics Recent Development
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Details
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Lipid-Based Nanodelivery System Introduction
11.10.4 Creative Biolabs Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.10.5 Creative Biolabs Recent Development
11.11 GenScript
11.11.1 GenScript Company Details
11.11.2 GenScript Business Overview
11.11.3 GenScript Lipid-Based Nanodelivery System Introduction
11.11.4 GenScript Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.11.5 GenScript Recent Development
11.12 WuXi STA
11.12.1 WuXi STA Company Details
11.12.2 WuXi STA Business Overview
11.12.3 WuXi STA Lipid-Based Nanodelivery System Introduction
11.12.4 WuXi STA Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.12.5 WuXi STA Recent Development
11.13 MicroNano Biologics
11.13.1 MicroNano Biologics Company Details
11.13.2 MicroNano Biologics Business Overview
11.13.3 MicroNano Biologics Lipid-Based Nanodelivery System Introduction
11.13.4 MicroNano Biologics Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.13.5 MicroNano Biologics Recent Development
11.14 Precigenome
11.14.1 Precigenome Company Details
11.14.2 Precigenome Business Overview
11.14.3 Precigenome Lipid-Based Nanodelivery System Introduction
11.14.4 Precigenome Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.14.5 Precigenome Recent Development
11.15 Catalent
11.15.1 Catalent Company Details
11.15.2 Catalent Business Overview
11.15.3 Catalent Lipid-Based Nanodelivery System Introduction
11.15.4 Catalent Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.15.5 Catalent Recent Development
11.16 Wacker
11.16.1 Wacker Company Details
11.16.2 Wacker Business Overview
11.16.3 Wacker Lipid-Based Nanodelivery System Introduction
11.16.4 Wacker Revenue in Lipid-Based Nanodelivery System Business (2020-2025)
11.16.5 Wacker Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Lipid-Based Nanodelivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of mRNA-lipid Nanoparticle
Table 3. Key Players of siRNA-lipid Nanoparticle
Table 4. Key Players of Liposomes
Table 5. Key Players of Other
Table 6. Global Lipid-Based Nanodelivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Lipid-Based Nanodelivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Lipid-Based Nanodelivery System Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Lipid-Based Nanodelivery System Market Share by Region (2020-2025)
Table 10. Global Lipid-Based Nanodelivery System Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Lipid-Based Nanodelivery System Market Share by Region (2026-2031)
Table 12. Lipid-Based Nanodelivery System Market Trends
Table 13. Lipid-Based Nanodelivery System Market Drivers
Table 14. Lipid-Based Nanodelivery System Market Challenges
Table 15. Lipid-Based Nanodelivery System Market Restraints
Table 16. Global Lipid-Based Nanodelivery System Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Lipid-Based Nanodelivery System Market Share by Players (2020-2025)
Table 18. Global Top Lipid-Based Nanodelivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid-Based Nanodelivery System as of 2024)
Table 19. Ranking of Global Top Lipid-Based Nanodelivery System Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Lipid-Based Nanodelivery System Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Lipid-Based Nanodelivery System, Headquarters and Area Served
Table 22. Global Key Players of Lipid-Based Nanodelivery System, Product and Application
Table 23. Global Key Players of Lipid-Based Nanodelivery System, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lipid-Based Nanodelivery System Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Lipid-Based Nanodelivery System Revenue Market Share by Type (2020-2025)
Table 27. Global Lipid-Based Nanodelivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Lipid-Based Nanodelivery System Revenue Market Share by Type (2026-2031)
Table 29. Global Lipid-Based Nanodelivery System Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Lipid-Based Nanodelivery System Revenue Market Share by Application (2020-2025)
Table 31. Global Lipid-Based Nanodelivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Lipid-Based Nanodelivery System Revenue Market Share by Application (2026-2031)
Table 33. North America Lipid-Based Nanodelivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Lipid-Based Nanodelivery System Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Lipid-Based Nanodelivery System Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Lipid-Based Nanodelivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Lipid-Based Nanodelivery System Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Lipid-Based Nanodelivery System Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Lipid-Based Nanodelivery System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Lipid-Based Nanodelivery System Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Lipid-Based Nanodelivery System Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Lipid-Based Nanodelivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Lipid-Based Nanodelivery System Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Lipid-Based Nanodelivery System Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Lipid-Based Nanodelivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Lipid-Based Nanodelivery System Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Lipid-Based Nanodelivery System Market Size by Country (2026-2031) & (US$ Million)
Table 48. Cytiva Company Details
Table 49. Cytiva Business Overview
Table 50. Cytiva Lipid-Based Nanodelivery System Product
Table 51. Cytiva Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 52. Cytiva Recent Development
Table 53. Croda International Company Details
Table 54. Croda International Business Overview
Table 55. Croda International Lipid-Based Nanodelivery System Product
Table 56. Croda International Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 57. Croda International Recent Development
Table 58. Evonik Company Details
Table 59. Evonik Business Overview
Table 60. Evonik Lipid-Based Nanodelivery System Product
Table 61. Evonik Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 62. Evonik Recent Development
Table 63. Merck KGaA Company Details
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Lipid-Based Nanodelivery System Product
Table 66. Merck KGaA Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 67. Merck KGaA Recent Development
Table 68. Genevant Sciences Company Details
Table 69. Genevant Sciences Business Overview
Table 70. Genevant Sciences Lipid-Based Nanodelivery System Product
Table 71. Genevant Sciences Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 72. Genevant Sciences Recent Development
Table 73. Nippon Fine Chemical Company Details
Table 74. Nippon Fine Chemical Business Overview
Table 75. Nippon Fine Chemical Lipid-Based Nanodelivery System Product
Table 76. Nippon Fine Chemical Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 77. Nippon Fine Chemical Recent Development
Table 78. Polymun Scientific Company Details
Table 79. Polymun Scientific Business Overview
Table 80. Polymun Scientific Lipid-Based Nanodelivery System Product
Table 81. Polymun Scientific Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 82. Polymun Scientific Recent Development
Table 83. Corden Pharma Company Details
Table 84. Corden Pharma Business Overview
Table 85. Corden Pharma Lipid-Based Nanodelivery System Product
Table 86. Corden Pharma Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 87. Corden Pharma Recent Development
Table 88. Acuitas Therapeutics Company Details
Table 89. Acuitas Therapeutics Business Overview
Table 90. Acuitas Therapeutics Lipid-Based Nanodelivery System Product
Table 91. Acuitas Therapeutics Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 92. Acuitas Therapeutics Recent Development
Table 93. Creative Biolabs Company Details
Table 94. Creative Biolabs Business Overview
Table 95. Creative Biolabs Lipid-Based Nanodelivery System Product
Table 96. Creative Biolabs Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 97. Creative Biolabs Recent Development
Table 98. GenScript Company Details
Table 99. GenScript Business Overview
Table 100. GenScript Lipid-Based Nanodelivery System Product
Table 101. GenScript Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 102. GenScript Recent Development
Table 103. WuXi STA Company Details
Table 104. WuXi STA Business Overview
Table 105. WuXi STA Lipid-Based Nanodelivery System Product
Table 106. WuXi STA Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 107. WuXi STA Recent Development
Table 108. MicroNano Biologics Company Details
Table 109. MicroNano Biologics Business Overview
Table 110. MicroNano Biologics Lipid-Based Nanodelivery System Product
Table 111. MicroNano Biologics Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 112. MicroNano Biologics Recent Development
Table 113. Precigenome Company Details
Table 114. Precigenome Business Overview
Table 115. Precigenome Lipid-Based Nanodelivery System Product
Table 116. Precigenome Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 117. Precigenome Recent Development
Table 118. Catalent Company Details
Table 119. Catalent Business Overview
Table 120. Catalent Lipid-Based Nanodelivery System Product
Table 121. Catalent Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 122. Catalent Recent Development
Table 123. Wacker Company Details
Table 124. Wacker Business Overview
Table 125. Wacker Lipid-Based Nanodelivery System Product
Table 126. Wacker Revenue in Lipid-Based Nanodelivery System Business (2020-2025) & (US$ Million)
Table 127. Wacker Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report


List of Figures
Figure 1. Lipid-Based Nanodelivery System Picture
Figure 2. Global Lipid-Based Nanodelivery System Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Lipid-Based Nanodelivery System Market Share by Type: 2024 VS 2031
Figure 4. mRNA-lipid Nanoparticle Features
Figure 5. siRNA-lipid Nanoparticle Features
Figure 6. Liposomes Features
Figure 7. Other Features
Figure 8. Global Lipid-Based Nanodelivery System Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Lipid-Based Nanodelivery System Market Share by Application: 2024 VS 2031
Figure 10. Gene Therapy Case Studies
Figure 11. Vaccine Case Studies
Figure 12. Cancer Treatment Case Studies
Figure 13. Others Case Studies
Figure 14. Lipid-Based Nanodelivery System Report Years Considered
Figure 15. Global Lipid-Based Nanodelivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Lipid-Based Nanodelivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Lipid-Based Nanodelivery System Market Share by Region: 2024 VS 2031
Figure 18. Global Lipid-Based Nanodelivery System Market Share by Players in 2024
Figure 19. Global Lipid-Based Nanodelivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Lipid-Based Nanodelivery System Revenue in 2024
Figure 21. North America Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Lipid-Based Nanodelivery System Market Share by Country (2020-2031)
Figure 23. United States Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Lipid-Based Nanodelivery System Market Share by Country (2020-2031)
Figure 27. Germany Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Lipid-Based Nanodelivery System Market Share by Region (2020-2031)
Figure 35. China Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Lipid-Based Nanodelivery System Market Share by Country (2020-2031)
Figure 43. Mexico Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Lipid-Based Nanodelivery System Market Share by Country (2020-2031)
Figure 47. Israel Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Lipid-Based Nanodelivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Cytiva Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 51. Croda International Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 52. Evonik Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 53. Merck KGaA Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 54. Genevant Sciences Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 55. Nippon Fine Chemical Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 56. Polymun Scientific Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 57. Corden Pharma Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 58. Acuitas Therapeutics Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 59. Creative Biolabs Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 60. GenScript Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 61. WuXi STA Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 62. MicroNano Biologics Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 63. Precigenome Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 64. Catalent Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 65. Wacker Revenue Growth Rate in Lipid-Based Nanodelivery System Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies